Clinical Trial: Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase 1 Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Brief Summary: The aim of this study was to analyze the safety, pulmonary function, and imaging changes of patients with silicosis treated with autologous bone marrow stromal cells with modification by hepatocyte growth factor.
Detailed Summary:
Sponsor: Wei Yu
Current Primary Outcome: Absence of lung deficits during the procedure and/or in the 6 months follow-up [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Improvement of pulmonary deficits [ Time Frame: 1 year ]
Original Secondary Outcome: Same as current
Information By: Guangzhou Municipal Twelfth People's Hospital
Dates:
Date Received: October 30, 2013
Date Started: June 2010
Date Completion:
Last Updated: November 20, 2013
Last Verified: November 2013